Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Intangibles (2017 - 2025)

BioCorRx's Intangibles history spans 11 years, with the latest figure at $3.0 million for Q3 2025.

  • For Q3 2025, Intangibles rose 36886.77% year-over-year to $3.0 million; the TTM value through Sep 2025 reached $3.0 million, up 36886.77%, while the annual FY2024 figure was $7848.0, 13.06% down from the prior year.
  • Intangibles for Q3 2025 was $3.0 million at BioCorRx, down from $3.1 million in the prior quarter.
  • Across five years, Intangibles topped out at $3.1 million in Q1 2025 and bottomed at $7848.0 in Q4 2024.
  • The 5-year median for Intangibles is $10353.5 (2022), against an average of $360369.0.
  • The largest annual shift saw Intangibles plummeted 92.96% in 2022 before it soared 36886.77% in 2025.
  • A 5-year view of Intangibles shows it stood at $11385.0 in 2021, then fell by 10.36% to $10206.0 in 2022, then dropped by 11.55% to $9027.0 in 2023, then decreased by 13.06% to $7848.0 in 2024, then surged by 38277.08% to $3.0 million in 2025.
  • Per Business Quant, the three most recent readings for BICX's Intangibles are $3.0 million (Q3 2025), $3.1 million (Q1 2025), and $7848.0 (Q4 2024).